Theratechnologies Announces End of Patient Treatment for Phase III Ibalizumab Trial
MONTREAL, QUEBEC--(Marketwired - Oct 24, 2016) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that it has been notified today by its partner, TaiMed Biologics, Inc., that the last patient enrolled in the Phase III study of …